Read Full Story: https://investingnews.com/news/biotech-investing/bristol-myers-squibbs-applications-for-deucravacitinib-for-the-treatment-of-moderate-to-severe-plaque-psoriasis-accepted-by-u.s.food-and-drug-administration-and-validated-by-european-medicines-agency/
Your content is great. However, if any of the content contained herein violates any rights of yours, including those of copyright, please contact us immediately by e-mail at media[@]kissrpr.com.